US RE49,880 E1
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
Alaric J. Dyckman, Lawrenceville, NJ (US); Dharmpal S. Dodd, Princeton, NJ (US); John E. Macor, Washington Crossing, PA (US); Christopher P. Mussari, Princeton, NJ (US); Laxman Pasunoori, Warangal (IN); Sreekantha Ratna Kumar, Bangalore (IN); Trevor C. Sherwood, West Windsor, NJ (US); and Ramesh Kumar Sistla, Bangalore (IN)
Assigned to BRISTOL-MYERS SQUIBB COMPANY, Princeton, NJ (US)
Filed by Bristol-Myers Squibb Company, Princeton, NJ (US)
Filed on Jan. 25, 2022, as Appl. No. 17/584,139.
Application 17/584,139 is a reissue of application No. 15/635,055, filed on Jun. 27, 2017, granted, now 10,071,079, issued on Sep. 11, 2018.
Claims priority of application No. 201611022328 (IN), filed on Jun. 29, 2016.
Int. Cl. A61K 31/4196 (2006.01); A61K 31/437 (2006.01); A61K 31/4427 (2006.01); A61K 45/06 (2006.01); C07D 249/00 (2006.01); C07D 471/04 (2006.01)
CPC A61K 31/4196 (2013.01) [A61K 31/437 (2013.01); A61K 31/4427 (2013.01); A61K 45/06 (2013.01); C07D 249/00 (2013.01); C07D 471/04 (2013.01)] 20 Claims
 
5. The [ A ] compound according to claim 4. [ having the structure:

OG Complex Work Unit Chemistry
]